Related Experiment Video
Updated: Jan 10, 2026

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
T-2 toxin exacerbates chondrocyte extracellular matrix degradation potentially through YAP/NLRP3/GSDMD-mediated
Haonan Li1, Zhifeng Xing1, Hexuan Dong2
1Institute for Kashin-Beck Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin 150081, Heilongjiang, China.; National Healthy Commission and Education Bureau of Heilongjiang Province, Key Laboratory of Etiology and Epidemiology, Harbin Medical University (23618504), Heilongjiang Provincial Laboratory of Trace Element and Human Health, Harbin Medical University, Harbin 150081, China.
Abstract:
Kashin-Beck disease (KBD) is an endemic osteoarthropathy, with T-2 toxin recognized as a major pathogenic factor. This study investigates the role of the YAP/NLRP3/GSDMD signaling pathway in T-2 toxin-induced cartilage injury. Differentially expressed genes associated with KBD were retrieved from PubMed and subjected to KEGG pathway enrichment analysis, revealing significant enrichment of the Hippo signaling pathway. Elevated serum levels of IL-1β, IL-18, and LDH were observed in KBD patients. In both in vivo and in vitro models, T-2 toxin inhibited Hippo/YAP signaling and promoted the nuclear translocation of YAP while activating NLRP3/GSDMD-mediated pyroptosis and extracellular matrix (ECM) degradation. Inhibition of YAP by verteporfin effectively suppressed NLRP3/GSDMD pathway activation and alleviated ECM degradation, whereas YAP overexpression further exacerbated pyroptosis and ECM damage. These findings indicate that YAP activation mediates chondrocyte pyroptosis and exacerbates ECM degradation, potentially through the NLRP3/GSDMD pathway, representing a key mechanism underlying T-2 toxin-induced cartilage injury and a potential therapeutic target.
Insights
T-2 toxin causes cartilage damage in Kashin-Beck disease by activating the YAP/NLRP3/GSDMD pathway. Inhibiting YAP protects against this damage, highlighting a potential therapeutic target for this endemic osteoarthropathy.
Area of Science:
- Biochemistry
- Pathology
- Molecular Biology
Background:
- Kashin-Beck disease (KBD) is an endemic osteoarthropathy linked to T-2 toxin.
- The pathogenic mechanisms of T-2 toxin-induced cartilage injury require further elucidation.
Purpose of the Study:
- To investigate the role of the YAP/NLRP3/GSDMD signaling pathway in T-2 toxin-induced cartilage injury.
- To identify potential therapeutic targets for KBD.
Main Methods:
- KEGG pathway enrichment analysis of KBD-associated genes from PubMed.
- Analysis of serum levels of IL-1β, IL-18, and LDH in KBD patients.
- In vivo and in vitro experiments using T-2 toxin models, YAP inhibition (verteporfin), and YAP overexpression.
Main Results:
- T-2 toxin inhibited Hippo/YAP signaling, promoted YAP nuclear translocation, and activated NLRP3/GSDMD-mediated pyroptosis and extracellular matrix (ECM) degradation.
- Elevated serum IL-1β, IL-18, and LDH were observed in KBD patients.
- YAP inhibition alleviated pyroptosis and ECM degradation, while YAP overexpression exacerbated these effects.
Conclusions:
- YAP activation mediates T-2 toxin-induced chondrocyte pyroptosis and ECM degradation via the NLRP3/GSDMD pathway.
- The YAP/NLRP3/GSDMD pathway represents a key mechanism in KBD pathogenesis and a potential therapeutic target.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway
The Extrinsic Apoptotic Pathway
Role of Matrix Metalloproteases in Degradation of ECM

